204 related articles for article (PubMed ID: 22234520)
1. A short half-life of the administered factor XIII (FXIII) concentrates after the first replacement therapy in a newborn with severe congenital FXIII deficiency.
Fujii N; Souri M; Ichinose A
Thromb Haemost; 2012 Mar; 107(3):592-4. PubMed ID: 22234520
[No Abstract] [Full Text] [Related]
2. [Congenital factor XIII deficiency required high-dose factor XIII concentrate in late pregnancy].
Takahashi T; Hatao K; Suzukawa M; Oji T
Rinsho Ketsueki; 2007 May; 48(5):418-20. PubMed ID: 17571589
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and safety of plasma-derived factor XIII concentrate (human) in patients with congenital factor XIII deficiency.
Nugent DJ; Ashley C; García-Talavera J; Lo LC; Mehdi AS; Mangione A
Haemophilia; 2015 Jan; 21(1):95-101. PubMed ID: 25458735
[TBL] [Abstract][Full Text] [Related]
4. Alloantibodies against the B subunit of plasma factor XIII developed in its congenital deficiency.
Wada H; Souri M; Matsumoto R; Sugihara T; Ichinose A
Thromb Haemost; 2013 Apr; 109(4):661-8. PubMed ID: 23407795
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of prophylactic treatment with plasma-derived factor XIII concentrate (human) in patients with congenital factor XIII deficiency.
Ashley C; Chang E; Davis J; Mangione A; Frame V; Nugent DJ
Haemophilia; 2015 Jan; 21(1):102-8. PubMed ID: 25377187
[TBL] [Abstract][Full Text] [Related]
6. Factor XIII: congenital deficiency factor XIII, acquired deficiency, factor XIII A-subunit, and factor XIII B-subunit.
Tahlan A; Ahluwalia J
Arch Pathol Lab Med; 2014 Feb; 138(2):278-81. PubMed ID: 24476525
[TBL] [Abstract][Full Text] [Related]
7. Molecular modeling predicts structural changes in the A subunit of factor XIII caused by two novel mutations identified in a neonate with severe congenital factor XIII deficiency.
Souri M; Yee VC; Fujii N; Ichinose A
Thromb Res; 2012 Sep; 130(3):506-10. PubMed ID: 22633530
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of recombinant factor XIII in young children with congenital FXIII deficiency and comparison with older patients.
Williams M; Will A; Stenmo C; Rosholm A; Tehranchi R
Haemophilia; 2014 Jan; 20(1):99-105. PubMed ID: 23834599
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and tolerability of factor XIII concentrates prepared from human placenta or plasma: a crossover randomised study.
Brackmann HH; Egbring R; Ferster A; Fondu P; Girardel JM; Kreuz W; Masure R; Miloszewski K; Stibbe J; Zimmermann R
Thromb Haemost; 1995 Aug; 74(2):622-5. PubMed ID: 8584996
[TBL] [Abstract][Full Text] [Related]
10. [Half-life of FXIII in vitro after infusion of placental concentrates in a patient with a congenital deficiency].
Vicente V; Alberca I; de Cecilia A; Portero JA; López Borrasca A
Sangre (Barc); 1984; 29(1):42-6. PubMed ID: 6719319
[No Abstract] [Full Text] [Related]
11. Molecular characterization of a novel mutation in the factor XIII a subunit gene associated with a severe defect: importance of prophylactic substitution.
Morange P; Trigui N; Frère C; Chambost H; Pouymayou C; Uters M; Boucly C; Juhan-Vague I; de Mazancourt P
Blood Coagul Fibrinolysis; 2009 Oct; 20(7):605-6. PubMed ID: 19713833
[TBL] [Abstract][Full Text] [Related]
12. Congenital deficiency of factor XIII caused by two missense mutations in a Dutch family.
Onland W; Böing AN; Meijer AB; Schaap MC; Nieuwland R; Haasnoot K; Sturk A; Peters M
Haemophilia; 2005 Sep; 11(5):539-47. PubMed ID: 16128900
[TBL] [Abstract][Full Text] [Related]
13. [Factor XIII : Pharmacodynamic and pharmacokinetic characteristics].
Adam EH; Kreuer S; Zacharowski K; Weber CF; Wildenauer R
Anaesthesist; 2017 Jan; 66(1):52-59. PubMed ID: 27942785
[TBL] [Abstract][Full Text] [Related]
14. Tailored prophylaxis with rFXIII (NovoThirteen
Zanon E; Pasca S; Radu C; Scattolo N; Spiezia L; Simioni P
Haemophilia; 2019 May; 25(3):e206-e208. PubMed ID: 30888101
[No Abstract] [Full Text] [Related]
15. Factor XIII deficiency enhances thrombin generation due to impaired fibrin polymerization - An effect corrected by Factor XIII replacement.
Pitkänen HH; Jouppila A; Lemponen M; Ilmakunnas M; Ahonen J; Lassila R
Thromb Res; 2017 Jan; 149():56-61. PubMed ID: 27902939
[TBL] [Abstract][Full Text] [Related]
16. Recombinant factor XIII A-subunit in a patient with factor XIII deficiency and recurrent pregnancy loss.
Al-Khabori M; Pathare A; Menegatti M; Peyvandi F
J Thromb Haemost; 2018 Jun; 16(6):1052-1054. PubMed ID: 29665207
[TBL] [Abstract][Full Text] [Related]
17. Long-term prophylaxis in patients with severe congenital factor XIII deficiency is not complicated by inhibitor formation.
Naderi M; Ahmadinejad M; Hosseini MS; Moradi E; Dorgalaleh A; Shamsizadeh M
Blood Coagul Fibrinolysis; 2017 Jun; 28(4):276-278. PubMed ID: 27306330
[TBL] [Abstract][Full Text] [Related]
18. Use of Factor XIII (FXIII) concentrate in patients with congenital FXIII deficiency undergoing surgical procedures.
Janbain M; Nugent DJ; Powell JS; St-Louis J; Frame VB; Leissinger CA
Transfusion; 2015 Jan; 55(1):45-50. PubMed ID: 25070582
[TBL] [Abstract][Full Text] [Related]
19. An unusual clinical presentation of factor XIII deficiency and issues relating to the monitoring of factor XIII replacement therapy.
Dargaud Y; de Mazancourt P; Rugeri L; Hanss M; Borg JY; Gaucherand P; Negrier C; Trzeciak C
Blood Coagul Fibrinolysis; 2008 Jul; 19(5):447-52. PubMed ID: 18600098
[TBL] [Abstract][Full Text] [Related]
20. Clinical experience with a pasteurised human plasma concentrate in factor XIII deficiency.
Daly HM; Haddon ME
Thromb Haemost; 1988 Apr; 59(2):171-4. PubMed ID: 3388293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
